MedPath

Impact of Catheter Stabilization on Catheter Micro-Motion and Functio

Not Applicable
Conditions
Phlebitis
Thrombosis
Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system
Registration Number
ACTRN12623000328673
Lead Sponsor
Griffith University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

•Female or Male sex
•18-65 years of age
•Not pregnant at time of recruitment and within 48 hrs of Day 1 procedures (self-reported)
•Normal haemotology results as per reference range determined by our laboratory.
•Normal coagulation results as per reference range determined by our laboratory.
•Target cephalic veins readily cannulatable (i.e., equal to approximately 2 mm)
•Able and willing to provide verbal and written consent
•Must be an Australian citizen with current Medicare card

Exclusion Criteria

•History of pro coagulative state / condition (e.g., previous deep vein thrombosis)
•Currently on any anti-coagulant or platelet inhibitor medication. Use of NSAIDs and aspirin will be documented however are not exclusionary.
•Haemophilia or any current or history of bleeding disorder or tendency
•Presence or report of current blood borne disease/infection (e.g., hepatitis, HIV, leukemia, lymphoma)
•Difficult vascular access (i.e., vein must be readily palpable and cannulatable – no less than approximately 2 mm diameter
•Allergy or sensitivity to chlorhexidine gluconate, isopropyl alcohol, latex, or skin adhesives
•BMI less than 18.5 kg/m^2 or greater than 35 kg/m^2
•Positive results for the urine drug screen at screening or check-in (including opiates, methadone, cocaine, amphetamines)
•History or presence of alcoholism (self-reported) or drug abuse within the past 2 years
•A current or previous medical, physical, mental / cognitive disorder or anatomical conditions that, in the opinion of the chief or sub-investigator, would place the patient at risk, would make them unable to perform study procedures or has the potential to confound interpretation of the study results. (e.g., musculo-skeletal injury, chronic back pain)
•Employed by Becton Dickinson, Teleflex Medical, ICUMedical or BBraun (conflict of interest)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath